Blockchain and COVID-19
initiated by the FDA in 2019 to evaluate product track , trace , and verification technologies in the pharmaceutical supply chain . Several of these DSCSA pilot projects , such as MediLedger , DSCSA blockchain interoperability pilot , Tracelink , and UCLA-LedgerDomain , evaluated the use of blockchain . Overall , the pilot programs found that blockchain can be used to meet the DSCSA requirements that continue to be phased in and will be fully enforced by 2023 so that it can help improve transparency and increase patient safety ,” explains Joseph .
Blockchain and COVID-19
Covid-19 has revealed some of the fragilities in supply chains and has hastened the process of adoption of technologies such as blockchain to improve the robustness of supply chains . This acceleration of the adoption of technology is expected to continue in the coming years .
- Arul Joseph , Senior Director , Pharmaceutical Development and Clinical Supply Chain , Avanir Pharmaceuticals
manufacturingglobal . com 105